Recent Developments in Biomarkers and Subgroups in Drug Development


20th March 2019

PGN Conference Centre, AstraZeneca, Pepparedsleden 1431 83 Mölndal, Swedan

Biomarkers continue to be present in modern drug development. Ideally, they may help scientists to understand why a patient responds in a particular way to treatment. In this meeting, experts from industry, academia and regulatory agencies will come together to share recent insights and discuss these challenges, with a focus on practical applications.

For the event flyer please Click Here